Status:
COMPLETED
Kavalactones on Sleep and Cortisol in Healthy Special Forces Trainees
Lead Sponsor:
Thorne HealthTech, Inc
Collaborating Sponsors:
Performance First
Conditions:
Sleep
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This research study is being done to better understand the effects of kava supplementation on sleep quality and salivary cortisol in the context of the acute physical and psychological stress of milit...
Detailed Description
Acute physical and behavioral stress can interfere with sleep quality and cause cortisol to increase. This can have a negative impact on quality of life and the ability to perform optimally. Kava, de...
Eligibility Criteria
Inclusion
- Age 18 or older
- Provides consent to participate in the study
- Understands and agrees to follow all study procedures and limitations
Exclusion
- Female
- Use of kava within the past 8 weeks
- Use of over the counter or prescription sleep aids including dietary supplements within the past 8 weeks
- Use of acetaminophen that cannot be discontinued or replaced with an NSAID during the study
- Known liver disease or dysfunction
- Known kidney disease or dysfunction
- Any prior adverse reaction or known sensitivity or allergy to kava or related botanicals (peppers)
- Recent history of clinical depression or anxiety diagnosis
Key Trial Info
Start Date :
May 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 9 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05381025
Start Date
May 11 2022
End Date
October 9 2022
Last Update
October 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Performance First
Virginia Beach, Virginia, United States, 23453